Evidence map›Paper›PMID 16028076›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2005

Silence of the transcripts: RNA interference in medicine.

Sailen Barik

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Article
  5. Review
  6. Article
  7. siRNA Versus miRNA as Therapeutics for Gene Silencing.Molecular therapy. Nucleic acids · 2015
    Review
  8. Therapy of respiratory viral infections with intranasal siRNAs.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  9. Article
  10. Article
  11. Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  12. Article
  13. Article
  14. Intranasal delivery of antiviral siRNA.Methods in molecular biology (Clifton, N.J.) · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sailen BarikDepartment of Biochemistry and Molecular Biology, College of Medicine, MSB2370, University of South Alabama, Mobile, 36688-0002, USA. sbarik@jaguar1.usouthal.edu
University of South Alabama · US

Funding

Interactions between ocular tissue and RSVR01EY013826 · NEI · UNIVERSITY OF SOUTH ALABAMA · PI BARIK, SAILEN · 2002 to 2004
$545k
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR011174 · NCRR · UNIVERSITY OF SOUTH ALABAMA · PI ABEE, CHRISTIAN R · 1995 to 1995
–
NCRR NIH HHS C06 RR11174NEI NIH HHS EY013826NIAID NIH HHS AI04583
6 · The paper itself

Abstract

Silencing of gene expression by ribonucleic acid (RNA), known as RNA interference (RNAi), is now recognized as a major means of gene regulation in biology. In this mechanism, small noncoding double-stranded RNA molecules knock down gene expression through a variety of mechanisms that include messenger RNA (mRNA) degradation, inhibition of mRNA translation, or chromatin remodeling. The posttranscriptional mechanism of RNAi has been embraced by researchers as a powerful tool for generating deficient phenotypes without mutating the gene. In parallel, exciting recent results have promised its application in disease therapy. This review aims to summarize the current knowledge in this area and provide a roadmap that may eventually launch RNAi from the research bench to the medicine chest.

Indexed as

RNA InterferenceAnimalsCommunicable DiseasesGenetic Diseases, InbornHumansInterferonsMetabolic DiseasesMiceMicroRNAsRNA, Small InterferingTranscription, GeneticInterferonsMicroRNAsRNA, Small Interfering

Identifiers

PMID16028076
OpenAlexW2125593589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.